In the study, we investigated the expression of survivin and three ABC transporters in patients with DLBCL and analyzed correlations between IHC expression and clinicopathological parameters and their potential predictive values to the R-CHOP treatment response. This evidence concerns the gene BIRC5 and diffuse large B-cell lymphoma.